Definitive Contract 75F40126C00019

This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Malcova LLC for $452,397. The contract calls for the development of patient-derived anthropomorphic breast phantoms for automated objective assessment of breast x-ray imaging systems. This supports the National Institutes of Health and Centers for Disease Control and Prevention's missions by responding to the 2019 solicitation seeking Small Business Innovation Research proposals related to...

This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a "CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...

The Department of Health and Human Services Food and Drug Administration awarded a $311,442 firm fixed price purchase order to General Electric Company for the procurement of a digital breast tomosynthesis system with installation and training. The contract calls for GE Healthcare, a division of General Electric, to deliver a digital indirect conversion detector and acquisition workstation that is no more than four years old, along with an x-ray tube and generator from 2018 or later....

This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...

The Department of Health and Human Services Food and Drug Administration awarded a $329,470 firm fixed price purchase order to Digim Solution LLC for image processing, modeling and simulation software. The solicitation sought a platform capable of image analysis, data management, computing resource management, quantitative data extraction, predictive simulation, and FDA 21 CFR Part 11 compliance to assess product quality attributes. Performance will take place in Woburn, Massachusetts through...

The U.S. Food and Drug Administration (FDA) awarded a $2,725,588.00 definitive cost-no-fee contract to the Arkansas Research Alliance for scientific and methodological advancements in liquid biopsies to further the development of lung cancer-based precision medicine. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 10, 2016. The contract does not have a set-aside designation. The Arkansas Research Alliance is the prime contractor for this award.

The Food and Drug Administration awarded a $1.79M firm fixed-price purchase order to Siemens Government Technologies Inc. on June 29, 2021, for modeling, simulation, and demonstration capabilities to evaluate smart design and manufacturing processes for shortage mitigation and supply chain resilience. The contract, which was not subject to a set-aside designation, was performed at the contractor's facility in Reston, Virginia, and had an ultimate completion date of October 31, 2024. This...

This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...

This $436,800 firm fixed price contract was awarded by the Department of Health and Human Services Food and Drug Administration to Research Triangle Institute - doing business as R T I International, with place of performance in Research Triangle Park, North Carolina. The contract is for HDDISWP#115 BENEFIT-RISK PREFERENCES FOR THE USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN IMAGING DIAGNOSTICS, with a period of performance from September 2020 through December 2022. The award was made...

<p>The Food and Drug Administration awarded a purchase order to Siemens Industry Software Inc. for an integration platform of process analytical technology systems and digital twin technology for lyophilization, valued at $199,779.12, with an award date of September 30, 2025. Performance will be completed by September 29, 2026 and will take place in Silver Spring, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>